These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28049853)

  • 1. Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.
    Le Nouën C; McCarty T; Brown M; Smith ML; Lleras R; Dolan MA; Mehedi M; Yang L; Luongo C; Liang B; Munir S; DiNapoli JM; Mueller S; Wimmer E; Collins PL; Buchholz UJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E386-E395. PubMed ID: 28049853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.
    Le Nouën C; McCarty T; Yang L; Brown M; Wimmer E; Collins PL; Buchholz UJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion mutations in phosphoprotein P of a codon-pair-deoptimized human respiratory syncytial virus confer increased transcription, immunogenicity, and genetic stability without loss of attenuation.
    Chen JW; Yang L; Santos C; Hassan SA; Collins PL; Buchholz UJ; Le Nouën C
    PLoS Pathog; 2021 Dec; 17(12):e1010191. PubMed ID: 34965283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization.
    Le Nouën C; Brock LG; Luongo C; McCarty T; Yang L; Mehedi M; Wimmer E; Mueller S; Collins PL; Buchholz UJ; DiNapoli JM
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13169-74. PubMed ID: 25157129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication
    Le Nouën C; Luongo CL; Yang L; Mueller S; Wimmer E; DiNapoli JM; Collins PL; Buchholz UJ
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters.
    Levy M; Chen JW; Kaiser JA; Park HS; Liu X; Yang L; Santos C; Buchholz UJ; Le Nouën C
    PLoS Pathog; 2024 May; 20(5):e1012198. PubMed ID: 38739647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding.
    Le Nouën C; Collins PL; Buchholz UJ
    Front Immunol; 2019; 10():1250. PubMed ID: 31231383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes.
    Meng J; Lee S; Hotard AL; Moore ML
    mBio; 2014 Sep; 5(5):e01704-14. PubMed ID: 25249281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Afroz S; Saul S; Dai J; Surman S; Liu X; Park HS; Le Nouën C; Lingemann M; Dahal B; Coleman JR; Mueller S; Collins PL; Buchholz UJ; Munir S
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2316376121. PubMed ID: 38861603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after
    Phan SI; Adam CM; Chen Z; Citron M; Liang X; Espeseth AS; Wang D; He B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.
    Whitehead SS; Hill MG; Firestone CY; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 1999 Dec; 73(12):9773-80. PubMed ID: 10559287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.
    Connors M; Crowe JE; Firestone CY; Murphy BR; Collins PL
    Virology; 1995 Apr; 208(2):478-84. PubMed ID: 7747420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.
    Whitehead SS; Firestone CY; Karron RA; Crowe JE; Elkins WR; Collins PL; Murphy BR
    J Virol; 1999 Feb; 73(2):871-7. PubMed ID: 9882287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes.
    Whitehead SS; Firestone CY; Collins PL; Murphy BR
    Virology; 1998 Aug; 247(2):232-9. PubMed ID: 9705916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.
    Karron RA; Buonagurio DA; Georgiu AF; Whitehead SS; Adamus JE; Clements-Mann ML; Harris DO; Randolph VB; Udem SA; Murphy BR; Sidhu MS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13961-6. PubMed ID: 9391135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates.
    Luongo C; Yang L; Winter CC; Spann KM; Murphy BR; Collins PL; Buchholz UJ
    Vaccine; 2009 Sep; 27(41):5667-76. PubMed ID: 19646406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate.
    Wang B; Yang C; Tekes G; Mueller S; Paul A; Whelan SP; Wimmer E
    mBio; 2015 Mar; 6(2):. PubMed ID: 25827413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics.
    Luongo C; Winter CC; Collins PL; Buchholz UJ
    J Virol; 2012 Oct; 86(19):10792-804. PubMed ID: 22837193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.